24 May 2013
Keywords: Hikma, Baxter Healthcare, USA, Antitrust, M&A, Phenytoin, Promethazine
Article | 29 April 2011
The USA’s Federal Trade Commission will require Jordan-based drugmaker Hikma Pharmaceuticals (LSE: HIK; Dubai: HIK) to divest two ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 April 2011
27 April 2011
3 May 2011
© 2013 thepharmaletter.com